These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8. Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR. Eur J Drug Metab Pharmacokinet; 2006; 31(4):299-309. PubMed ID: 17315542 [Abstract] [Full Text] [Related]
4. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. Ma L, Sun J, Peng Y, Zhang R, Shao F, Hu X, Zhu J, Wang X, Cheng X, Zhu Y, Wan P, Feng D, Wu H, Wang G. Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289 [Abstract] [Full Text] [Related]
5. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Watanabe Y, Nakajima M, Yokoi T. Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820 [Abstract] [Full Text] [Related]
6. Human UDP-glucuronosyltransferase 1As catalyze aristolochic acid D O-glucuronidation to form a lesser nephrotoxic glucuronide. Tu DZ, Liu PQ, Zhu GH, Zeng HR, Deng YY, Huang J, Niu XT, Liu YF, Hu J, Liang XM, Finel M, Wang P, Ge GB. J Ethnopharmacol; 2024 Jun 28; 328():118116. PubMed ID: 38548118 [Abstract] [Full Text] [Related]
7. Glucuronidation of D-Luciferin In Vitro: Isoform Selectivity and Kinetics Characterization. Xia Y, Pang H. Eur J Drug Metab Pharmacokinet; 2019 Aug 28; 44(4):549-556. PubMed ID: 30820844 [Abstract] [Full Text] [Related]
8. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin. Xin H, Xia YL, Hou J, Wang P, He W, Yang L, Ge GB, Xu W. J Pharm Pharmacol; 2015 Dec 28; 67(12):1673-81. PubMed ID: 26407805 [Abstract] [Full Text] [Related]
9. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver. Mano Y, Usui T, Kamimura H. Pharm Res; 2006 Jul 28; 23(7):1502-8. PubMed ID: 16783480 [Abstract] [Full Text] [Related]
12. Identification and characterization of human UDP-glucuronosyltransferases responsible for xanthotoxol glucuronidation. He G, Troberg J, Lv X, Xia YL, Zhu LL, Ning J, Ge GB, Finel M, Yang L. Xenobiotica; 2018 Feb 28; 48(2):109-116. PubMed ID: 28689454 [Abstract] [Full Text] [Related]
14. Characterization of the glucuronidating pathway of pectolinarigenin, the major active constituent of the Chinese medicine Daji, in humans and its influence on biological activities. Liu P, Li Q, Zhu G, Zhang T, Tu D, Zhang F, Finel M, He Y, Ge G. J Ethnopharmacol; 2024 Jan 30; 319(Pt 1):117280. PubMed ID: 37797876 [Abstract] [Full Text] [Related]
17. Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes. Wang L, Hong X, Yao Z, Dai Y, Zhao G, Qin Z, Wu B, Gonzalez FJ, Yao X. Xenobiotica; 2018 Apr 30; 48(4):357-367. PubMed ID: 28443723 [Abstract] [Full Text] [Related]
18. 6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1H-Indole-3-Carboxylic Acid is a Highly Selective Substrate for Glucuronidation by UGT1A1, Relative to β-Estradiol. Lapham K, Lin J, Novak J, Orozco C, Niosi M, Di L, Goosen TC, Ryu S, Riccardi K, Eng H, Cameron KO, Kalgutkar AS. Drug Metab Dispos; 2018 Dec 30; 46(12):1836-1846. PubMed ID: 30194276 [Abstract] [Full Text] [Related]